Cole Douglas G.
Transaction: 06/24/2026
BUY
Change
+28,000
Price
$4.08
Filing
06/25/2026
Type
BUY
Foghorn Therapeutics Inc.
FHTX • Biotechnology
$4.92
▲ +0.05 (+1.03%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$347.50M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 92.8%Healthy liquidity · 2.73Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:33 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.92
Change1.03%
Shares Out70.63M
Market Cap$347.50M
Enterprise Value$223.02M
52W Range3.27 - 6.95
Beta2.86
P/E-5.38
P/S9.46
P/B-4.29
P/FCF-4.07
EV/Sales6.07
Price$4.92
Change1.03%
Shares Out70.63M
Market Cap$347.50M
Enterprise Value$223.02M
52W Range3.27 - 6.95
Beta2.86
P/E-5.38
P/S9.46
P/B-4.29
P/FCF-4.07
EV/Sales6.07
EV/EBITDA-3.57
EV/FCF-2.61
Earnings Yield-18.58%
FCF Yield-24.56%
Dividend Yield0.00%
Gross Margin89.22%
Oper. Margin-2.66%
Profit Margin-2.40%
Debt/Eq-0.38
Current Ratio2.73
Quick Ratio2.73
Target$13.86
Target Upside181.71%
Target Median$12.00
Target Range9.00 - 20.00
Volume13.06K
Avg Volume243.45K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Positive revenue growth · 92.8%Healthy liquidity · 2.73Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
94/100
Bullish
Bullish
8
Hold
1
Bearish
0
Price Target
2026-08-07
Low
$12.00
Mean
$12.00
Median
$12.00
High
$12.00
Insider Transactions
Recent executive and insider activity
PARSHALL B LYNNE
Transaction: 06/24/2026
BUY
Change
+28,000
Price
$4.08
Filing
06/25/2026
Type
BUY
GILL SIMBA
Transaction: 06/24/2026
BUY
Change
+28,000
Price
$4.08
Filing
06/25/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Cole Douglas G. | BUY | +28,000 | $4.08 | 06/24/2026 | 06/25/2026 |
| PARSHALL B LYNNE | BUY | +28,000 | $4.08 | 06/24/2026 | 06/25/2026 |
| GILL SIMBA | BUY | +28,000 | $4.08 | 06/24/2026 | 06/25/2026 |
| SMITH IAN F | BUY | +28,000 | $4.08 | 06/24/2026 | 06/25/2026 |
| Mendelsohn Michael | BUY | +28,000 | $4.08 | 06/24/2026 | 06/25/2026 |
| Gallagher Neil | BUY | +28,000 | $4.08 | 06/24/2026 | 06/25/2026 |
| Biller Scott | BUY | +28,000 | $4.08 | 06/24/2026 | 06/25/2026 |
| Duty Stuart | BUY | +28,000 | $4.08 | 06/24/2026 | 06/25/2026 |
| Lynch Thomas J. Jr. | BUY | +28,000 | $4.08 | 06/24/2026 | 06/25/2026 |
| GOTTSCHALK ADRIAN | SELL | -59,208 | Not reported | 04/10/2026 | 04/13/2026 |
| GOTTSCHALK ADRIAN | SELL | -47,497 | Not reported | 04/09/2026 | 04/13/2026 |
| Maynard Ryan D | OTHER | 0 | Not reported | 02/23/2026 | 02/24/2026 |
| Maynard Ryan D | BUY | +400,000 | $5.75 | 02/23/2026 | 02/24/2026 |
| GOTTSCHALK ADRIAN | BUY | +1,075,000 | $5.23 | 02/05/2026 | 02/06/2026 |
| Bellon Steven F. | BUY | +300,000 | $5.71 | 01/30/2026 | 02/02/2026 |
| Rivkin Anna | BUY | +165,000 | $5.71 | 01/30/2026 | 02/02/2026 |
| Cardama Alfonso Quintas | BUY | +300,000 | $5.71 | 01/30/2026 | 02/02/2026 |
| LaCascia Michael | BUY | +295,000 | $5.71 | 01/30/2026 | 02/02/2026 |
| Costa Carlos | BUY | +230,000 | $5.71 | 01/30/2026 | 02/02/2026 |
| Flagship Pioneering, LLC | BUY | +1,117,734 | $20.13 | 01/13/2026 | 01/15/2026 |